Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF- κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo

In conclusion, this study reveals that the suppression of PKC-δ, and the p38 MAPK/NF-κB axis is associated with the lenvatinib-inhibited progression of HCC in vitro and in vivo.PMID:34864311 | DOI:10.1016/j.biopha.2021.112437

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - December 5, 2021 Category: Drugs & Pharmacology Authors: Ching-Hsuan Wu Fei-Ting Hsu Tsu-Lan Chao Yuan-Hao Lee Yu-Cheng Kuo Source Type: research